Buy Keurig Dr Pepper because beverage stock prices are too risky, Morgan Stanley says

Morgan Stanley says Keurig Dr Pepper is “poised to regain its pop after losing its high caffeine content.” The firm said in a note on Thursday that the “significant underperformance of the stock” created a buying opportunity for investors. Analyst Dara Mohsenian upgraded the stock to overweight from equal weight. His $36 price target means […]